Testicular Germ Cell Tumor clinical trials

The registry lists 85 studies for Testicular Germ Cell Tumor across more than 10 countries. 10 are recruiting or about to start. 26 of them are mainly about Testicular Germ Cell Tumor (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-04.

Get an email when these change. Save the Testicular Germ Cell Tumor studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed: 53
Terminated: 10
Status unknown: 8
Recruiting: 7
Not yet recruiting: 2
Active, not recruiting: 2

Phase

Phase 2: 37
Phase 1: 18
Phase 3: 13

Where

United States: 51
United Kingdom: 18
France: 9
Netherlands: 6
Denmark: 5
Germany: 5

Who runs them

Memorial Sloan Kettering Cancer Center (10) · Fred Hutchinson Cancer Center (5) · Medical Research Council (5) · European Organisation for Research and Treatment of Cancer - EORTC (4) · UNICANCER (3) · Royal Marsden NHS Foundation Trust (3) · Eastern Cooperative Oncology Group (3) · Case Comprehensive Cancer Center (2)

What is being tested here

Drugs under test in Testicular Germ Cell Tumor studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug	Phase 3	All
Ifosfamide	2	11
Paclitaxel	3	9
Carboplatin	1	9
Etoposide	2	9
Cisplatin	1	5
Cyclophosphamide	0	3
Gemcitabine	0	2
Pegfilgrastim	0	2
Filgrastim	0	2
Granisetron	1	2

Drug classes tested here Alkylating agents 17 · Antimitotic agents 11 · Corticosteroids 3

Coming up

0phase 3 studies under way

2studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 2

Dec 2026A Study of HFB200301 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid Tumors · HiFiBiO Therapeutics
Oct 2027Enfortumab Vedotin With or Without Pembrolizumab in Rare Genitourinary Tumors (E-VIRTUE) · National Cancer Institute (NCI)

Who these studies take

Of the 7 Testicular Germ Cell Tumor studies recruiting now, 4 (57%) set no upper age limit and 2 (29%) stop at 75 or younger. 2 (29%) take children under 18. 0 (0%) are for women only and 4 (57%) for men only; 0 (0%) take healthy volunteers.

Recruiting studies that take each age, of 7
Age	Women	Men
10	0 (0%)	0 (0%)
18	3 (43%)	7 (100%)
30	3 (43%)	7 (100%)
40	3 (43%)	7 (100%)
50	2 (29%)	6 (86%)
65	2 (29%)	5 (71%)
75	2 (29%)	5 (71%)
85	2 (29%)	5 (71%)

Across all 85 studies, recruiting or not: 25% stop at 75 or younger and 20% at 65; 48% take children; 0% are for women only and 38% for men only; 1% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

Studies

Recruiting first, then most recently updated. Showing 50 of 85. Browse all 85 → or search them.